Risk factors and survival outcomes in patients with brain metastases from breast cancer. (Q50899949)

25 March 2018

title

Risk factors and survival outcomes in patients with brain metastases from breast cancer. (English)

1 reference

25 March 2018

1 reference

10

1 reference

25 March 2018

Michela Guardascione

1 reference

ORCID Public Data File 2021

author name string

A M Minisini

1

1 reference

25 March 2018

S Moroso

2

1 reference

25 March 2018

L Gerratana

3

1 reference

25 March 2018

M Giangreco

4

1 reference

25 March 2018

D Iacono

5

1 reference

25 March 2018

E Poletto

6

1 reference

25 March 2018

M Guardascione

7

1 reference

25 March 2018

C Fontanella

8

1 reference

25 March 2018

G Fasola

9

1 reference

25 March 2018

publication date

18 June 2013

1 reference

25 March 2018

Clinical & Experimental Metastasis

published in

1 reference

25 March 2018

volume

30

1 reference

25 March 2018

page(s)

951-956

1 reference

25 March 2018

issue

8

1 reference

25 March 2018

https://scigraph.springernature.com/pub.10.1007/s10585-013-9594-5

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Is breast cancer survival improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Metastatic behavior of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

The natural history of breast cancer patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Brain metastases free survival differs between breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Breast carcinoma: Pattern of metastasis at autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Brain metastases: epidemiology and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

CNS metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Lung metastasis genes couple breast tumor size and metastatic spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Breast cancer metastasis to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-013-9594-5

Management of brain metastases

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23775210

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10585-013-9594-5

1 reference

25 March 2018

PubMed ID

23775210

1 reference

25 March 2018